利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

417 条记录 (耗时 0.03 秒)

    Server and method for providing device management service and device receiving the device management service
    2.
    发明授权
    Server and method for providing device management service and device receiving the device management service 有权
    用于提供设备管理服务和接收设备管理服务的设备的服务器和方法

    公开(公告)号：US09425982B2

    公开(公告)日：2016-08-23

    申请号：US13150932

    申请日：2011-06-01

    申请人： Ji-Hye Lee ,  Wuk Kim

    发明人： Ji-Hye Lee ,  Wuk Kim

    IPC分类号： H04L12/28 ,  H04W4/00 ,  H04L12/24

    CPC分类号： H04L12/2874 ,  H04L12/2889 ,  H04L41/0233 ,  H04W4/50 ,  H04W4/70

    摘要： A method for providing a Device Management (DM) service in an M2M environment that enables intelligent data collection and communication through an M2M communication function is provided. In the method, a Network Operator Server (NOS) or an ES provides a DM service menu to a subscriber device. When the subscriber device selects a desired service from the DM service menu, the NOS delegates the DM service authority for a network subscriber to the ES. The ES provides the DM service through an M2M communication with the subscriber device. The ES integrates the DM results and transmits the integrated DM results to the network operator. Accordingly, the NOS can provide an efficient DM service to more devices at a lower cost, by minimal interaction with the ES, through the cooperation enterprise specialized in the DM service.

    摘要翻译： 提供了一种在通过M2M通信功能实现智能数据收集和通信的M2M环境中提供设备管理（DM）服务的方法。 在该方法中，网络运营商服务器（NOS）或ES向订户设备提供DM服务菜单。 当用户设备从DM服务菜单中选择所需的服务时，NOS将网络用户的DM服务机构委托给ES。 ES通过与订户设备的M2M通信来提供DM服务。 ES集成了DM结果，并将集成的DM结果发送给网络运营商。 因此，NOS可以通过专门从事DM服务的合作企业，通过与ES的最小交互，以更低的成本向更多的设备提供高效的DM服务。

    N1-cyclic amine-N5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same
    3.
    发明授权
    N1-cyclic amine-N5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same 有权
    N 1 - 环胺-N 5取代双胍衍生物，其制备方法和包含其的药物组合物

    公开(公告)号：US09321742B2

    公开(公告)日：2016-04-26

    申请号：US14237546

    申请日：2012-08-08

    申请人： Sung Wuk Kim ,  Chang Hee Min ,  Se Hwan Park ,  Duck Kim ,  Ji Sun Lee ,  Yong Eun Kim ,  Ju Hoon Oh

    发明人： Sung Wuk Kim ,  Chang Hee Min ,  Se Hwan Park ,  Duck Kim ,  Ji Sun Lee ,  Yong Eun Kim ,  Ju Hoon Oh

    IPC分类号： C07C279/26 ,  C07C29/16 ,  C07D205/04 ,  C07D213/40 ,  C07D295/215 ,  C07D333/20 ,  C07D307/52

    CPC分类号： C07D295/215 ,  C07D205/04 ,  C07D213/40 ,  C07D307/52 ,  C07D333/20

    摘要： A N1-cyclic amine-N5-substituted biguanide derivative of Formula 1 or a pharmaceutically acceptable salt thereof, a method of manufacturing the same, and a pharmaceutical composition including the biguanide derivative or the pharmaceutically acceptable salt thereof as an active ingredient are provided. The biguanide derivatives have an effect of inhibiting cancer cell proliferation and also exhibit anticancer activity including inhibition of cancer metastasis and cancer recurrence, because they are effective in activating AMPK, which is associated with the control of energy metabolism, even when administered in a small dose compared with conventional drugs. Also, the biguanide derivatives are highly effective at lowering blood glucose and lipid concentration by AMPK activation, thus they may be effectively used to treat diabetes mellitus, obesity, hyperlipemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovary syndrome and metabolic syndrome.

    摘要翻译： 提供式1的N 1 - 环胺-N 5 - 取代双胍衍生物或其药学上可接受的盐，其制备方法和包含双胍衍生物或其药学上可接受的盐作为活性成分的药物组合物。 双胍衍生物具有抑制癌细胞增殖的作用，并且还表现出抗肿瘤活性，包括抑制癌症转移和癌症复发，因为即使以小剂量施用也能有效地激活与能量代谢控制有关的AMPK 与常规药物相比。 此外，双胍衍生物通过AMPK活化降低血糖和脂质浓度高度有效，因此可有效用于治疗糖尿病，肥胖症，高脂血症，高胆固醇血症，脂肪肝，冠状动脉疾病，骨质疏松症，多囊卵巢综合征和代谢 综合征

    Method for determining location of UE by using AGPS information
    4.
    发明授权
    Method for determining location of UE by using AGPS information 有权
    使用AGPS信息确定UE位置的方法

    公开(公告)号：US09148782B2

    公开(公告)日：2015-09-29

    申请号：US13407263

    申请日：2012-02-28

    申请人： Wuk Kim ,  Joo-Young Kim ,  Joon-Goo Park

    发明人： Wuk Kim ,  Joo-Young Kim ,  Joon-Goo Park

    IPC分类号： H04W24/00 ,  H04W12/02 ,  G01S5/00 ,  G01S19/05 ,  G01S19/25 ,  H04L29/06 ,  H04W4/02

    CPC分类号： H04W12/02 ,  G01S5/0036 ,  G01S19/05 ,  G01S19/25 ,  H04L63/0407 ,  H04W4/02

    摘要： A method and apparatus are disclosed for providing location information of a User Equipment (UE) in a communication system including the UE, a Secure User Plane Location (SUPL) Location Center (SLC), and a SUPL Positioning Center (SPC). The method includes receiving, by the SLC, a request for the location information of the UE from a requester; notifying, by the SLC, the UE that the location information has been requested; transmitting, by the SLC to the SPC, a pseudo IDentifier (ID) for securing a connection between the SPC and the SLC; receiving, by the SLC from the SPC, the location information of the UE with the pseudo ID, the location information of the UE being calculated by the SPC, based on a positioning measurement measured by the UE; and transmitting, by the SLC, the location information to the requester.

    摘要翻译： 公开了一种用于在包括UE，安全用户平面位置（SUPL）位置中心（SLC）和SUPL定位中心（SPC）的通信系统中提供用户设备（UE）的位置信息的方法和装置。 该方法包括：通过SLC从请求者接收对UE的位置信息的请求; 由SLC通知UE已经请求了位置信息; 通过SLC向SPC发送用于确保SPC和SLC之间的连接的伪标识符（ID）; 基于由UE测量的定位测量结果，通过SLC从SPC接收具有伪ID的UE的位置信息，由SPC计算的UE的位置信息; 并通过SLC将位置信息发送给请求者。

    Mold structure, patterning method using the same, and method of fabricating liquid crystal display device
    6.
    发明授权
    Mold structure, patterning method using the same, and method of fabricating liquid crystal display device 有权
    模具结构，使用其的图案化方法以及制造液晶显示装置的方法

    公开(公告)号：US08932041B2

    公开(公告)日：2015-01-13

    申请号：US11966571

    申请日：2007-12-28

    申请人： Jin Wuk Kim

    发明人： Jin Wuk Kim

    IPC分类号： B29C33/38

    CPC分类号： B29C59/10 ,  B29C33/3857 ,  B29C33/40 ,  B29C33/424 ,  B29C37/0053 ,  B29K2105/0002 ,  B29L2031/3475 ,  G02F1/1303 ,  G02F1/133516 ,  G02F1/13394

    摘要： A mold structure, a patterning method thereof and a method of fabricating an LCD device using the same are disclosed, which can realize a conformal contact by applying a voltage between a mold structure and a material layer being opposite to each other in an In-Plane Printing process, so as to prevent defective patterns, wherein the mold structure comprises a mold whose surface is provided with patterns; a backplane for supporting the mold; and a conductive film formed between the backplane and the mold.

    摘要翻译： 公开了一种模具结构，其构图方法以及使用该模具结构的LCD装置的制造方法，其可以通过在平面内在模具结构和彼此相对的材料层之间施加电压来实现保形接触 印刷工艺，以防止不良图案，其中模具结构包括其表面设有图案的模具; 用于支撑模具的背板; 以及形成在背板和模具之间的导电膜。

    N1-Cyclic Amine-N5-Substituted Biguanide Derivatives, Methods of Preparing the Same and Pharmaceutical Composition Comprising the Same
    7.
    发明申请
    N1-Cyclic Amine-N5-Substituted Biguanide Derivatives, Methods of Preparing the Same and Pharmaceutical Composition Comprising the Same 有权
    N1环状胺-N5取代双胍衍生物，其制备方法和药物组合物

    公开(公告)号：US20140179661A1

    公开(公告)日：2014-06-26

    申请号：US14237546

    申请日：2012-04-08

    申请人： Sung Wuk Kim ,  Chang Hee Min ,  Se Hwan Park ,  Duck Kim ,  Ji Sun Lee ,  Yong Eun Kim ,  Ju Hoon Oh

    发明人： Sung Wuk Kim ,  Chang Hee Min ,  Se Hwan Park ,  Duck Kim ,  Ji Sun Lee ,  Yong Eun Kim ,  Ju Hoon Oh

    IPC分类号： C07D295/215 ,  C07D205/04 ,  C07D333/20 ,  C07D213/40 ,  C07D307/52

    CPC分类号： C07D295/215 ,  C07D205/04 ,  C07D213/40 ,  C07D307/52 ,  C07D333/20

    摘要： A N1-cyclic amine-N5-substituted biguanide derivative of Formula 1 or a pharmaceutically acceptable salt thereof, a method of manufacturing the same, and a pharmaceutical composition including the biguanide derivative or the pharmaceutically acceptable salt thereof as an active ingredient are provided. The biguanide derivatives have an effect of inhibiting cancer cell proliferation and also exhibit anticancer activity including inhibition of cancer metastasis and cancer recurrence, because they are effective in activating AMPK, which is associated with the control of energy metabolism, even when administered in a small dose compared with conventional drugs. Also, the biguanide derivatives are highly effective at lowering blood glucose and lipid concentration by AMPK activation, thus they may be effectively used to treat diabetes mellitus, obesity, hyperlipemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovary syndrome and metabolic syndrome.

    摘要翻译： 提供式1的N 1 - 环胺-N 5 - 取代双胍衍生物或其药学上可接受的盐，其制备方法和包含双胍衍生物或其药学上可接受的盐作为活性成分的药物组合物。 双胍衍生物具有抑制癌细胞增殖的作用，并且还表现出抗肿瘤活性，包括抑制癌症转移和癌症复发，因为即使以小剂量施用也能有效地激活与能量代谢控制有关的AMPK 与常规药物相比。 此外，双胍衍生物通过AMPK活化降低血糖和脂质浓度高度有效，因此可有效用于治疗糖尿病，肥胖症，高脂血症，高胆固醇血症，脂肪肝，冠状动脉疾病，骨质疏松症，多囊卵巢综合征和代谢 综合征

    Liquid crystal display
    10.
    发明授权
    Liquid crystal display 有权
    液晶显示器

    公开(公告)号：US08605242B2

    公开(公告)日：2013-12-10

    申请号：US12902465

    申请日：2010-10-12

    申请人： Seon-Ah Cho ,  Jang-Kun Song ,  Hyun-Wuk Kim

    发明人： Seon-Ah Cho ,  Jang-Kun Song ,  Hyun-Wuk Kim

    IPC分类号： G02F1/1337 ,  G02F1/136 ,  G02F1/1343

    CPC分类号： G02F1/134309 ,  G02F1/133707 ,  G02F1/133753 ,  G02F1/13624 ,  G02F2001/134345

    摘要： A liquid crystal display includes a signal line disposed on a substrate, a pixel electrode connected to the signal line and including a first subpixel electrode and a second subpixel electrode, a common electrode disposed opposite the pixel electrode, and a liquid crystal layer disposed between the pixel electrode and the common electrode. The liquid crystal layer is divided into domains including a first direction domain and a second direction domain in a region corresponding to the first subpixel electrode, and a third direction domain and a fourth direction domain in a region corresponding to the second subpixel electrode, and an area of the third direction domain is greater than about twice and less than about then times an area of the fourth direction domain.

    摘要翻译： 液晶显示器包括设置在基板上的信号线，连接到信号线的像素电极，包括第一子像素电极和第二子像素电极，与像素电极相对设置的公共电极，以及设置在该像素电极之间的液晶层 像素电极和公共电极。 液晶层在与第一子像素电极对应的区域中分为第一方向域和第二方向域，在与第二子像素电极对应的区域中分为第三方向域和第四方向域， 第三方向域的面积大于第二方向结构域的面积的大约两倍且小于大约的时间。